These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36898675)

  • 21. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.
    Yendt ER; Cohanim M
    N Engl J Med; 1985 Apr; 312(15):953-7. PubMed ID: 3974685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperoxaluria, hyperglycoluria and renal oxalosis in Gilbert's potoroos (Potorous gilbertii).
    Forshaw D; Horwitz AM; Ellard K; Friend JA; Greed L; Metz M
    Aust Vet J; 2017 Jul; 95(7):250-258. PubMed ID: 28653383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1.
    Illies F; Bonzel KE; Wingen AM; Latta K; Hoyer PF
    Kidney Int; 2006 Nov; 70(9):1642-8. PubMed ID: 16955107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extraction of glyceric and glycolic acids from urine with tetrahydrofuran: utility in detection of primary hyperoxaluria.
    Dietzen DJ; Wilhite TR; Kenagy DN; Milliner DS; Smith CH; Landt M
    Clin Chem; 1997 Aug; 43(8 Pt 1):1315-20. PubMed ID: 9267307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical screening algorithm for primary hyperoxaluria type 1 in adults on dialysis.
    Ferraro PM; D'Ambrosio V; Gambaro G; Giachino D; Groothoff J; Mandrile G
    Nephrol Dial Transplant; 2024 Jan; 39(2):367-370. PubMed ID: 37708050
    [No Abstract]   [Full Text] [Related]  

  • 26. Development and Validation of a New Gas Chromatography-Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure.
    van Harskamp D; Garrelfs SF; Oosterveld MJS; Groothoff JW; van Goudoever JB; Schierbeek H
    Anal Chem; 2020 Jan; 92(2):1826-1832. PubMed ID: 31867958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
    Scheinman JI; Voziyan PA; Belmont JM; Chetyrkin SV; Kim D; Hudson BG
    Urol Res; 2005 Nov; 33(5):368-71. PubMed ID: 16292584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.
    Worcester EM; Evan AP; Coe FL; Lingeman JE; Krambeck A; Sommers A; Phillips CL; Milliner D
    Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1574-84. PubMed ID: 24089413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma oxalate and creatinine and oxalate/creatinine clearance ratios in normal subjects and in primary hyperoxaluria. Evidence for renal hyperoxaluria.
    Kasidas GP; Nemat S; Rose GA
    Clin Chim Acta; 1990 Oct; 191(1-2):67-77. PubMed ID: 2073734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.
    Tang X; Voskoboev NV; Wannarka SL; Olson JB; Milliner DS; Lieske JC
    Am J Nephrol; 2014; 39(5):376-82. PubMed ID: 24776840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-performance liquid chromatographic determination of plasma glycolic acid in healthy subjects and in cases of hyperoxaluria syndromes.
    Petrarulo M; Marangella M; Linari F
    Clin Chim Acta; 1991 Jan; 196(1):17-26. PubMed ID: 2022057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrocalcinosis in a patient with primary hyperoxaluria type 2.
    Kemper MJ; Müller-Wiefel DE
    Pediatr Nephrol; 1996 Aug; 10(4):442-4. PubMed ID: 8865239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycolate metabolism by Hep G2 cells.
    Holmes RP; Sexton WJ; Applewhite JC; Kennedy M; Assimos DG
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S345-7. PubMed ID: 10541260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1.
    Garrelfs SF; Metry EL; van Harskamp D; Vaz FM; van den Akker CHP; Schierbeek H; Groothoff JW; Oosterveld MJS
    Kidney Int; 2023 May; 103(5):990-993. PubMed ID: 36871948
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.
    Assimos DG
    J Urol; 2017 May; 197(5):1297-1298. PubMed ID: 29539912
    [No Abstract]   [Full Text] [Related]  

  • 36. Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.
    Fargue S; Milliner DS; Knight J; Olson JB; Lowther WT; Holmes RP
    J Am Soc Nephrol; 2018 Jun; 29(6):1615-1623. PubMed ID: 29588429
    [No Abstract]   [Full Text] [Related]  

  • 37. Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.
    Lorenz EC; Lieske JC; Seide BM; Olson JB; Mehta R; Milliner DS
    Am J Kidney Dis; 2021 May; 77(5):816-819. PubMed ID: 32891627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Type I oxalosis in childhood--studies within the scope of terminal renal failure in the child].
    Frosch M; Kuwertz-Bröking E; Bulla M; von Bassewitz DB; Leusmann DB
    Klin Wochenschr; 1989 Nov; 67(22):1156-67. PubMed ID: 2586021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxyproline ingestion and urinary oxalate and glycolate excretion.
    Knight J; Jiang J; Assimos DG; Holmes RP
    Kidney Int; 2006 Dec; 70(11):1929-34. PubMed ID: 17021603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THE METABOLIC DEFECT OF PRIMARY HYPEROXALURIA.
    SMITH LH; HOCKADAY TD; EFRON ML; CLAYTON JE
    Trans Assoc Am Physicians; 1964; 77():317-25. PubMed ID: 14275433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.